75 UG Pegylated Recombinant Human Erythropoietin Injection

Name: 75 UG Pegylated Recombinant Human Erythropoietin Injection
Brand: NEETCO BIOPHARMA
Price: 3800 INR
Availability: InStock

Price 3800 INR/ Vial

Get a Price/Quote

MOQ : 1 Vial

75 UG Pegylated Recombinant Human Erythropoietin Injection Specification

Dosage Guidelines
As directed by the physician

Assay
Conforms to specification

CAS No
1134276-27-0

HS Code
3002

Appearance
Clear, colorless solution

Melting Point
Not applicable (biologic)

Physical Form
Injection

Pacakaging (Quantity Per Box)
1 Pre-filled Syringe

Molecular Formula
C815H1317N233O241S5 (unpegylated, not including PEG moiety)

Suitable For
Adults

Solubility
Soluble in aqueous buffer

Purity
>98% (by SDS-PAGE)

Type
Recombinant Human Erythropoietin, PEGylated

Ingredients
Pegylated recombinant human erythropoietin, excipients, buffer

Feature
Long-acting erythropoiesis-stimulating agent

Shelf Life
24 months

Storage Instructions
Store between 2C - 8C, do not freeze

Pharmacopoeia Standard
As per manufacturer or Pharmacopoeia guidelines

Strength
75 g per syringe

Preservative
Preservative-free

Application
Treatment of anemia associated with chronic kidney disease and chemotherapy

Container Type
Pre-filled syringe (sterile, single dose)

Route of Administration
Subcutaneous or intravenous

About 75 UG Pegylated Recombinant Human Erythropoietin Injection

Introducing the new release 75 UG Pegylated Recombinant Human Erythropoietin Injection-a resplendent, kingly advancement for the management of anemia linked to chronic kidney disease and chemotherapy. Enjoy a fresh Price Cut on this best-in-class, long-acting erythropoiesis-stimulating agent. Carefully crafted as a clear, colorless solution in a sterile, single-dose pre-filled syringe, this preservative-free injection meets strict pharmacopoeia standards. With a stellar purity of over 98%, it delivers robust performance and patient comfort. Store between 2C - 8C; avoid freezing. Experience the pinnacle of innovative anemia therapy, now accessible in India through trusted distributors, exporters, and suppliers.

Who Benefits from 75 UG Pegylated Erythropoietin Injection?

Designed for adults, this injection is widely used by nephrologists and oncologists for patients undergoing treatment for anemia associated with chronic kidney disease or chemotherapy. Its long-acting formulation ensures extended erythropoiesis stimulation, reducing dosing frequency. The pre-filled, preservative-free syringe offers convenience, safety, and sterility. Its application by subcutaneous or intravenous route simplifies administration for healthcare professionals. The product stands out for meeting high efficacy and tolerability standards, making it suitable for diverse clinical settings.

Certifications, Outlay, and Packaging Details of the 75 UG PEG Erythropoietin Injection

This product aligns with recognized pharmacopoeia guidelines, assuring robust certification standards. Each purchase covers a single pre-filled syringe securely sealed for quality assurance. Delivered through established FOB ports across India, the exchange and outlay are designed to be seamless for international and local buyers alike. The packaging emphasizes product integrity, and each charge guarantees sterility, clarity, and safe handling. Your investment ensures a highly purified, reliable treatment for anemia management.

FAQ's of 75 UG Pegylated Recombinant Human Erythropoietin Injection:

Q: How should the 75 UG Pegylated Recombinant Erythropoietin Injection be stored?

A: Store the injection between 2C and 8C and do not freeze. Keep it in its original packaging until ready to use for maximum stability and effectiveness.

Q: What are the main benefits of PEGylated recombinant human erythropoietin for patients?

A: The PEGylated form offers a long-acting erythropoiesis-stimulating effect, reducing the need for frequent injections, enhancing patient comfort, and improving anemia management for those with chronic kidney disease or undergoing chemotherapy.

Q: When should this injection be administered?

A: Administration should follow a physician's direction and is typically integrated into anemia treatment protocols for adults with chronic kidney disease or those on chemotherapy. Dosage and scheduling are determined by the healthcare provider.

Q: Where can I purchase or order the 75 UG Pegylated Erythropoietin Injection?

A: This injection is distributed, exported, and supplied in India by authorized medical distributors, exporters, suppliers, and traders. Please consult healthcare procurement channels to place your order.

Q: What is the process for administering this injection?

A: The injection can be given subcutaneously or intravenously in a clinical setting by trained healthcare professionals. The pre-filled syringe design ensures sterile, single-use administration.

Q: How should the used syringe be disposed of?

A: After administration, the pre-filled syringe should be disposed of in a designated medical sharps container to ensure safe and responsible waste management.

Tell us about your requirement